Occurrence, removal and risk assessment of pharmaceutical and personal care products (PPCPs) in an advanced drinking water treatment plant (ADWTP) around Taihu Lake in China

Chemosphere

Volumn 152, Issue , 2016, Pages 1-9

  Lin, Tao ^a   Yu, Shilin ^a   Chen, Wei ^a  

^a HOHAI UNIVERSITY   (China)

Author keywords

ADWTP; PPCPs; Risk assessment; Taihu Lake

Indexed keywords

CHEMICAL WATER TREATMENT; EFFICIENCY; EFFLUENTS; HEALTH RISKS; LAKES; POTABLE WATER; PRINCIPAL COMPONENT ANALYSIS; PURIFICATION; WATER TREATMENT PLANTS;

ADWTP; HUMAN HEALTH RISK ASSESSMENT; PHARMACEUTICAL AND PERSONAL CARE PRODUCTS; PPCPS; PURIFICATION PROCESS; REMOVAL EFFICIENCIES; REMOVAL PERFORMANCE; TAIHU LAKES;

RISK ASSESSMENT;

ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM ANTAGONIST; CARBAMAZEPINE; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLARITHROMYCIN; DICLOFENAC; DISINFECTANT AGENT; DISOPYRAMIDE; DRINKING WATER; ERYTHROMYCIN; FRAGRANCE; IBUPROFEN; INDOMETACIN; INSECTICIDE; LINCOMYCIN; NEUROLEPTIC AGENT; PARACETAMOL; PERSONAL CARE PRODUCT; PESTICIDE; PHENAZONE; ROXITHROMYCIN; SULFAMETHOXAZOLE; TIAMULIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; VETERINARY DRUG; COSMETIC; DRUG; WATER POLLUTANT;

CONCENTRATION (COMPOSITION); DRINKING WATER; ECOTOXICOLOGY; HEALTH RISK; POLLUTANT REMOVAL; POLLUTION MONITORING; PPCP; RISK ASSESSMENT; TOXICITY TEST; WATER TREATMENT;

ADVANCED DRINKING WATER TREATMENT PLANT; AQUATIC ENVIRONMENT; ARTICLE; BIODEGRADATION; CHINA; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LAKE; OZONATION; PHYSICAL CHEMISTRY; RISK ASSESSMENT; SEDIMENTATION; SEWAGE EFFLUENT; SEWAGE TREATMENT PLANT; TANDEM MASS SPECTROMETRY; ADOLESCENT; ADULT; ANALYSIS; CHILD; ENVIRONMENTAL MONITORING; INFANT; PRESCHOOL CHILD; PROCEDURES; WATER MANAGEMENT; WATER POLLUTANT; YOUNG ADULT;

CHINA; TAIHU LAKE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHINA; COSMETICS; DRINKING WATER; ENVIRONMENTAL MONITORING; HUMANS; INFANT; LAKES; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION; YOUNG ADULT;

EID: 84959332226     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2016.02.109     Document Type: Article

References (67)

1. Arp H.P.H. Emerging decontaminants. Environ. Sci. Technol. 2012, 46(8):4259-4260.
2. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ. Sci. Technol. 2009, 43(3):597-603.
3. Behera S.K., Kim H.W., Oh J.E., Park H.S. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. Sci. Total Environ. 2011, 409(20):4351-4360.
4. Boleda M.R., Galceran M.T., Ventura F. Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments. Environ. Pollut. 2011, 159:1584-1591.
5. Boxall A.B.A., Rudd M.A., Brooks B.W., et al. Pharmaceuticals and personal care products in the environment: what are the big questions?. Environ. Health Perspect. 2012, 120:1221-1229.
6. Bu Q.W., Wang B., Huang J., Deng S.B., Yu G. Pharmaceuticals and personal care products in the aquatic environment in China: a review. J. Hazard. Mater. 2013, 262:189-211.
7. Buerge I.J., Kahle M., Buser H.R., Muller M.D., Poiger T. Nicotine derivatives in wastewater and surface waters: application as chemical markers for domestic wastewater. Environ. Sci. Technol. 2008, 42(17):6354-6360.
8. Choe H.S., Lee S.J., Han C.H., Shim B.S., Cho Y.H. Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial. J. Infect. Chemother. 2014, 20(1-2):20-25.
9. De-Voogt P., Janex-Habibi M.L., Sacher F., Puijker L., Mons M. Development of a common priority list of pharmaceuticals relevant for the water cycle. Water Sci. Technol. 2009, 59(1):39-45.
10. Dodd M.C., Buffle M.O., Von-Gunten U. Oxidation of antibacterial Molecules by aqueous ozone: moiety-specific reaction kinetics and application to ozone-based wastewater treatment. Environ. Sci. Technol. 2006, 40(6):1969-1977.
11. Esplugas S., Bila D.M., Krause L.G.T., et al. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. J. Hazard. Mater. 2007, 149(3):631-642.
12. Fan X.J., Tao Y., Wang L.Y., Zhang X.H., Lei Y., Wang Z., Noguchi H. Performance of an integrated process combining ozonation with ceramic membrane ultra-filtration for advanced treatment of drinking water. Desalination 2014, 335(1):47-54.
13. Fawell J., Ong C.N. Emerging contaminants and the implications for drinking water. Int. J. Water Resour. D. 2012, 28(2):247-263.
14. FDA, Food and Drug Administration Approved Drug Products with Therapeutic Equivalence Evaluations 2013, Center for Drug Evaluation and Research, Rockville, MD.
15. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76(2):122-159.
16. Göbel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372(2-3):361-371.
17. Grassi M., Rizzo L., Farina A. Endocrine disruptors compounds, pharmaceuticals and personal care products in urban wastewater: implications for agricultural reuse and their removal by adsorption process. Environ. Sci. Pollut. Res. 2013, 20(6):3616-3628.
18. He Y.J., Chen W., Zheng X.Y., Wang X.N., Huang X. Fate and removal of typical pharmaceuticals and personal care products by three different treatment processes. Sci. Total Environ. 2013, 447:248-254.
19. Hernando M.D., Mezcua M., Fernández-Alba A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69(2):334-342.
20. Hollender J., Zimmermann S.G., Koepke S., et al. Elimination of organic micropollutants in a municipal wastewater treatment plant upgraded with a full-scale post-ozonation followed by sandfiltration. Environ. Sci. Technol. 2009, 43(20):7862-7869.
21. Hua W., Bennett E.R., Letcher R.J. Ozone treatment and the depletion of detectable pharmaceuticals and antrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water Res. 2006, 40(12):2259-2266.
22. Ikehata K., Jodeiri N.N., Gamal E.D. Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: a review. Ozone Sci. Eng. 2006, 28(6):353-414.
23. Jelic A., Gros M., Ginebreda A., et al. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 2011, 45(3):1165-1176.
24. Kim S.H., Shon H.K., Ngo H.H. Adsorption characteristics of antibiotics trimethoprim on powdered and granular activated carbon. J. Ind. Eng. Chem. 2010, 16(3):344-349.
25. Kosma C.I., Lambropoulou D.A., Albanis T.A. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment. Sci. Total Environ. 2014, 466-467:421-438.
26. Lange F., Cornelissen S., Kubac D., et al. Degradation of macrolide antibiotics by ozone: a mechanistic case study with clarithromycin. Chemosphere 2006, 65(1):17-23.
27. Le-Minh N., Khan S.J., Drewes J.E., Stuetz R.M. Fate of antibiotics during municipal water recycling treatment processes. Water Res. 2010, 44(15):4295-4323.
28. Leitner N.K.V., Roshani B. Kinetic of benzotriazole oxidation by ozone and hydroxyl radical. Water Res. 2010, 44(6):2058-2066.
29. Lindqvist N., Tuhkanen T., Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res. 2005, 39(11):2219-2228.
30. Lishman L., Smyth S.A., Smyth K., et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci. Total Environ. 2006, 367(2-3):544-558.
31. Liu J.C., Lu G.H., Wang Y.H., Yan Z.H., Yang X.F., Ding J.N., Jiang Z. Bioconcentration, metabolism, and biomarker responses in freshwater fish Carassius auratus exposed to roxithromycin. Chemosphere 2014, 99:102-108.
32. Liu J.L., Wong M.H. Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China. Environ. Int. 2013, 59:208-224.
33. Liu L.L., Zhu Y., Tang L., Cao W.X., Wang E. Impacts of climate changes, soil nutrients, variety types and management practices on rice yield in East China: a case study in the Taihu region. Field Crop. Res. 2013, 149:40-48.
34. Loraine G.A., Pettigrove M.E. Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in Southern California. Environ. Sci. Technol. 2006, 40(3):687-695.
35. Luo Y., Xu L., Rysz M., Wang Y., Zhang H., Alvarez P.J.J. Occurrence and transport of tetracycline, sulfonamide, quinolone, and macrolide antibiotics in the Haihe River basin, China. Environ. Sci. Technol. 2011, 45(5):1827-1833.
36. Mackay D., Barnthouse L. Integrated risk assessment of household chemicals and consumer products: addressing concerns about triclosan. Integr. Environ. Assess. Manag. 2010, 6(3):390-392.
37. Monteiro S.C., Boxall A.B.A. Factors affecting the degradation of pharmaceuticals in agricultural soils. Environ. Toxicol. Chem. 2009, 28(12):2546-2554.
38. Nakada N., Shinohara H., Murata A., et al. Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. Water Res. 2007, 41(19):4372-4382.
39. Padhye L.P., Yao H., Kungu F.T., Huang C.H. Year-long evaluation on the occurrence and fate of pharmaceuticals, personal care products, and endocrine disrupting chemicals in an urban drinking water treatment plant. Water Res. 2014, 51:266-276.
40. Qiang Z., Adams C., Surampalli R. Determination of ozonation rate constants for lincomycin and spectinomycin. Ozone Sci. Eng. 2004, 26:525-537.
41. Qiao T.J., Yu Z.R., Zhang X.H., Au D.W.T. Occurrence and fate of pharmaceuticals and personal care products in drinking water in Southern China. J. Environ. Monit. 2011, 13(11):3097-3103.
42. Radjenovic J., Godehardt M., Petrovic M., Hein A., Farre M., Jekel M., Barcelo D. Evidencing generation of persistent ozonation products of antibiotics roxithromycin and trimethoprim. Environ. Sci. Technol. 2009, 43(17):6808-6815.
43. Ratola N., Cincinelli A., Alves A., Katsoyiannis A. Occurrence of organic microcontaminants in the wastewater treatment process. A mini review. J. Hazard. Mater. 2012, 239:1-18.
44. Renner R. The Kow controversy. Environ. Sci. Technol. 2002, 36(21):410A-413A.
45. Schröder H.F., Tambosi J.L., Sena R.F., Moreira R.F.P.M., José H.J., Pinnekamp J. The removal and degradation of pharmaceutical compounds during membrane bioreactor treatment. Water Sci. Technol. 2012, 65(5):833-839.
46. Sim W.J., Lee J.W., Oh J.E. Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea. Environ. Pollut. 2010, 158(5):1938-1947.
47. Snyder S.A., Benotti J.M. Endocrine disruptors and pharmaceuticals: implications for water sustainability. Water Sci. Technol. 2010, 61(1):145-154.
48. Snyder S.A., Westerhoff P., Yoon Y., Sedlak D.L. Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry. Environ. Eng. Sci. 2003, 20(5):449-469.
49. Stackelberg P.E., Gibs J., Furlong E.T., Meyer M.T., Zaugg S.D., Lippincott R.L. Efficiency of conventional drinkingwater-treatment processes in removal of pharmaceuticals and other organic compounds. Sci. Total Environ. 2007, 377(2-3):255-272.
50. Suárez S., Lema J.M., Omil F. Pre-treatment of hospital wastewater by coagulation-flocculation and flotation. Bioresour. Technol. 2009, 100(7):2138-2146.
51. Sui Q., Huang J., Deng S., Yu G., Fan Q. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Res. 2010, 44(2):417-426.
52. Sun Q., Lv M., Hu A.Y., Yang X.Y., Yu C.P. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in a wastewater treatment plant in Xiamen, China. J. Hazard. Mater. 2014, 277:69-75.
53. Verlicchi P., Al-Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment -a review. Sci. Total Environ. 2012, 429:123-155.
54. Verlicchi P., Al-Aukidy M., Galletti A., Petrovic M., Barceló D. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci. Total Environ. 2012, 430:109-118.
55. Vieno N.M., Harkki H., Tuhkanen T., Kronberg L. Occurrence of pharmaceuticals in river water and their elimination a pilot-scale drinking water treatment plant. Environ. Sci. Technol. 2007, 41(14):5077-5084.
56. Vieno N., Tuhkanen T., Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res. 2007, 41(5):1001-1012.
57. Voogt P., Janex-Habibi M.L., Sacher F., Puijker L., Mons M. Development of a Common Priority List of Pharmaceuticals Relevant for the Water Cycle 2008, IWA World Water Congress and Exhibition, Vienna, Austria.
58. Vulliet E., Cren-Olive C., Grenier-Loustalot M.F. Occurrence of pharmaceuticals and hormones in drinking water treated from surface waters. Environ. Chem. Lett. 2011, 9(1):103-114.
59. Walsh C. Antibiotics: Actions, Origins, Resistance 2003, ASM Press, Washington, DC.
60. Wang C., Lu G.H., Wang P.F., Wu H., Qi P.D., Liang Y. Assessment of environmental pollution of Taihu Lake by combining active biomonitoring and integrated biomarker response. Environ. Sci. Technol. 2011, 45(8):3746-3752.
61. Wu Y.F., Jia Y.Z., Lu X.W. Assessment of semi-volatile organic compounds in drinking water sources in Jiangsu, China. Ecotoxicol. Environ. Saf. 2013, 94:138-146.
62. Yan Z.H., Yang X.F., Lu G.H., Liu J.C., Xie Z.X., Wu D.H. Potential environmental implications of emerging organic contaminants in Taihu Lake, China: comparison of two ecotoxicological assessment approaches. Sci. Total Environ. 2014, 470:171-179.
63. Yang X., Flowers R.C., Weinberg H.S., Singer P.C. Occurrence and removal of pharmaceuticals and personal care products (PPCPs) in an advanced wastewater reclamation plant. Water Res. 2011, 45(16):5218-5228.
64. Yu Z.Y., Jiang L., Yin D.Q. Behavior toxicity to Caenorhabditis elegans transferred to the progeny after exposure to sulfamethoxazole at environmentally relevant concentrations. J. Environ. Sci. 2011, 23(2):294-300.
65. Zhang Y., Guo C.S., Xu J., Tian Y.Z., Shi G.L., Feng Y.C. Potential source contributions and risk assessment of PAHs in sediments from Taihu Lake, China: comparison of three receptor models. Water Res. 2012, 46(9):3065-3073.
66. Zhao C.Y., Boriani E., Chana A., Roncaglioni A., Benfenati E. A new hybrid system of QSAR models for predicting bioconcentration factors (BCF). Chemosphere 2008, 73(11):1701-1707.
67. Zuccato E., Castiglioni S., Bagnati R., Melis M., Fanelli R. Source, occurrence and fate of antibiotics in the Italian aquatic environment. J. Hazard. Mater. 2010, 179(1-3):1042-1048.